JVATiTD - Articles

Official publication of CEVAP/UNESP
Research

Protective effects of mesenchymal stromal cell-derived secretome on dermonecrosis induced in rabbits by Loxosceles intermedia spider venom

Gabriela Marques Rodrigues1, Mara Elvira de Almeida1, Sóstenes Apolo Correia Marcelino1, Paula Bretas Ullmann Fernandes1, Jessica Oliveira Pereira da Cruz1, Françoise Louanne Araújo1, Raquel da Silva Ferreira1, Ana Flávia Machado Botelho1, Francisco Javier Bedoya2,3, Gladys Margot Cahuana2,3, Ana Belén Hitos4, Bernat Soria3,4, Fernanda Costal-Oliveira5, Clara Guerra Duarte6, Juan R. Tejedo2,3,7, Carlos Chávez-Olórtegui5*, Marília Martins Melo1* [ + show more ]

J Venom Anim Toxins incl Trop Dis, 2024, 30:e20240004
Received: 24 January 2024 | Accepted: 21 June 2024 | Published online: 22 July 2024
Collection: Spotlighting toxinology: from animal toxins to next-generation technologies and products
https://doi.org/10.1590/1678-9199-JVATITD-2024-0004

Abstract

Background: Loxoscelism refers to a set of clinical manifestations caused by the bite of spiders from the Loxosceles genus. The classic clinical symptoms are characterized by an intense inflammatory reaction at the bite site followed by local necrosis and can be classified as cutaneous loxoscelism. This cutaneous form presents difficult healing, and the proposed treatments are not specific or effective. This study aimed to evaluate the protective effect of mesenchymal stromal cells-derived secretome on dermonecrosis induced by Loxosceles intermedia spider venom in rabbits. Methods: Sixteen rabbits were distributed into four groups (n = 4). Except for group 1 (G1), which received only PBS, the other three groups (G2, G3, and G4) were initially challenged with 10 μg of L. intermedia venom, diluted in 100 μL of NaCl 0.9%, by intradermic injection in the interscapular region. Thirty minutes after the challenge all groups were treated with secretome, except for group 2. Group 1 (G1-control group) received intradermal injection (ID) of 60 μg of secretome in 0.15 M PBS; Group 2 (G2) received 0.9% NaCl via ID; Group 3 (G3) received 60 μg of secretome, via ID and Group 4 (G4), received 60 μg of secretome by intravenous route. Rabbits were evaluated dailyand after 15 days were euthanized, necropsied and skin samples around the necrotic lesions were collected for histological analysis. Results: Rabbits of G1 did not present edema, erythema, hemorrhagic halo, or necrosis. In animals from G2, G3, and G4, edema appeared after 6h. However, minor edema was observed in the animals of G2 and G3. Hemorrhagic halo was observed in animals, six hours and three days after, on G2, G3, and G4. Macroscopically, in G4, only one animal out of four had a lesion that evolved into a dermonecrotic wound. No changes were observed in the skin of the animals of G1, by microscopic evaluation. All animals challenged with L. intermedia venom showed similar alterations, such as necrosis and heterophilic infiltration. However, animals from G4 showed fibroblast activation, early development of connective tissue, neovascularization, and tissue re-epithelialization, indicating a more prominent healing process. Conclusion: These results suggest that secretome from mesenchymal stromal cells cultured in a xeno-free and human component-free culture media can be promising to treat dermonecrosis caused after Loxosceles spiders bite envenoming.

 

Keywords: Loxoscelism; Loxosceles intermedia; regenerative therapy; secretome.

Full Article PDF Press release
Top